CA
SGMO

Cetera Advisors’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History

Cetera Advisors’s Portfolio SGMO Stock Details SGMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-15,550
Closed -$282K – 625
2014
Q1 		$282K Buy
+15,550
New +$300K 0.04% 412

Other funds holding SGMO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
FCM
Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Cetera Advisors's SGMO Position: Q2 2014 in Review

Cetera Advisors sold out of SANGAMO THERAPEUTICS INC (SGMO) in Q2 2014, closing a stake of 15,550 shares — an estimated $282K sold.

Cetera Advisors first reported a position in SGMO in Q1 2014 and held it in 1 quarter. The position peaked at $282K in Q1 2014. 156 funds tracked by Wall St. Rank hold SGMO as of Q2 2014.

  • Cetera Advisors reported no remaining SANGAMO THERAPEUTICS INC position as of Q2 2014 after selling out during the quarter.
  • Cetera Advisors sold 15,550 SANGAMO THERAPEUTICS INC shares in Q2 2014, an estimated $282K.
  • Cetera Advisors first reported a position in SANGAMO THERAPEUTICS INC in Q1 2014 and held it in 1 quarter.
  • Cetera Advisors's SANGAMO THERAPEUTICS INC position peaked at $282K in Q1 2014.
  • 156 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q2 2014.

Based on Cetera Advisors's 13F filing for Q2 2014, filed 15 Aug 2014.